NFKB1 and keratoacanthoma: Therefore although NFκB inhibition in the epidermis can trigger a TNF-dependent inflammation that leads to impaired differentiation, epidermal hyperplasia and SCC, it is also possible that increased NF-κB activity in the skin can cause a TNF-independent proliferation leading to keratoacanthoma development (Table 1).